Why Farbe Firma is the Top Manufacturer of Ephedrine HCL Injection
- Maulik Sudani
- 4 hours ago
- 6 min read
Last Updated: May 29, 2026
TL;DR: Ephedrine HCL Injection — a sterile parenteral solution of the mixed-action sympathomimetic amine ephedrine hydrochloride, supplied most commonly as 30 mg/mL or 50 mg/mL in 1 mL clear-glass ampoules — is the first-line vasopressor for the prevention and treatment of anaesthesia-induced hypotension, particularly during spinal and epidural anaesthesia in obstetric and surgical patients. With both direct alpha- and beta-adrenergic agonist activity and an indirect noradrenaline-releasing action, a single 3–6 mg intravenous bolus restores systolic blood pressure within 60–90 seconds while preserving utero-placental and visceral perfusion. Farbe Firma Pvt Ltd manufactures WHO-GMP certified Ephedrine HCL Injection at our Gujarat, India facility and supplies it to anaesthesia services, obstetric units, hospital tenders, distributors and brand owners across 30+ countries.
Key Takeaways
Drug class: Mixed-action sympathomimetic amine — Ephedrine HCL Injection is the parenteral vasopressor of choice for anaesthesia-induced hypotension during spinal, epidural and combined spinal-epidural anaesthesia, including obstetric anaesthesia for caesarean delivery. As a mixed alpha- and beta-agonist with an indirect noradrenaline-releasing effect, it raises blood pressure while preserving heart rate and utero-placental perfusion.
Certified manufacturing: WHO-GMP certified plant, ISO Class 5 aseptic core, validated water-for-injection loops, qualified clear-glass ampoule filling lines, dedicated handling for a controlled-substance precursor with full chain-of-custody, controlled-temperature storage and segregated controlled-room access, validated terminal-sterilisation cycles and full container-closure integrity verification on every batch.
CTD-ACTD dossier support: Full eCTD and ACTD modules, ICH Q1A long-term and accelerated stability data, ICH Q1B photostability data, drug master files and CEP-style documentation for registrations — including ministry-of-health hospital, anaesthesia and obstetric tenders, with all chain-of-custody documentation required for ephedrine as a controlled-substance precursor.
End-to-end CDMO services: Contract manufacturing, third-party manufacturing, private-label artwork, multilingual leaflets, tender-ready ampoule packaging and logistics coordination for buyers in Africa, LATAM, CIS, GCC, MENA and Southeast Asia, with full import/export documentation for ephedrine-containing finished products.
Introduction: Why Ephedrine HCL Injection Demands a Premium Manufacturer
Ephedrine HCL Injection occupies an essential role on the anaesthesia trolley. It is the first vasopressor that anaesthetists draw up before performing a spinal block for a caesarean delivery, because spinal-induced sympathectomy reliably produces maternal hypotension that, untreated, jeopardises both maternal cardiac output and utero-placental perfusion. It is the rapid-onset, opioid-free option that surgical teams reach for when blood pressure falls during induction or maintenance of anaesthesia, and it is the agent of choice in epidural-related hypotension in orthopaedic and gynaecological cases. In each of these settings ephedrine is given as a 3–6 mg intravenous bolus and the patient is expected to respond within sixty to ninety seconds.
That clinical reality places real demands on the manufacturer. Ephedrine hydrochloride is a chiral sympathomimetic amine — the pharmacological activity sits in the (1R,2S)-(−)-ephedrine isomer — that is freely water soluble, weakly basic and chemically stable when formulated as a simple, near-neutral aqueous solution of the hydrochloride salt. It is, however, classified internationally as a controlled-substance precursor (Table I, 1988 UN Convention) and is regulated for chain-of-custody at every step from API to finished product. Assay precision is non-negotiable because anaesthetists titrate ephedrine in 3 mg or 6 mg increments against an actively falling blood pressure, often in a peri-partum mother. Choosing an Ephedrine HCL Injection manufacturer that treats controlled-substance chain-of-custody, single-enantiomer specification, pH control and particulate inspection as core engineering disciplines is what protects anaesthesia and obstetric care at the bedside.
What Sets a World-Class Ephedrine HCL Injection Manufacturer Apart
A world-class manufacturer of Ephedrine HCL Injection invests in three areas that weaker suppliers underfund: enantiomeric purity and assay precision of an actively titrated vasopressor, full chain-of-custody documentation for a controlled-substance precursor across API receipt, in-process holding, finished-product release and export, and tender-ready dossier support for a product that is universally procured through anaesthesia, obstetric and ministry-of-health channels. It starts with pharmacopoeial-grade ephedrine hydrochloride sourced from qualified, audited and licence-holding API manufacturers, with full enantiomeric and impurity profiling, related-substances control and certificates of analysis cross-checked before any material enters production.
Formulation, filling and packaging then have to protect both the molecule and the licence. The solution is built at a controlled near-neutral pH (around 4.5 to 7.0), with sodium chloride for tonicity where appropriate, and is filled under ISO Class 5 air into 1 mL clear-glass ampoules with light-protective secondary packaging. In-process assay confirms label strength, container-closure integrity is verified on every batch, and stability is tracked under ICH Q1A long-term and accelerated conditions as well as ICH Q1B photostability protocols. Critically, the entire flow — from API receipt and weighing through bulk solution preparation, filling, inspection, labelling, packing and dispatch — is recorded on a controlled-substance ledger with daily reconciliation and segregated controlled-room access.
Quality Systems Behind Every Ephedrine HCL Injection
Every Farbe Firma Ephedrine HCL Injection batch is released only after a full stack of quality checks: HPLC assay against USP, BP, IP or EP reference standards including chiral verification of the (1R,2S)-(−)-ephedrine isomer, related-substances and degradation-product profiling, pH, osmolarity, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, container-closure integrity, and fill-volume verification for the 1 mL ampoule format at both 30 mg/mL and 50 mg/mL strengths. Certificates of analysis are issued with full traceability back to API lot, primary-packaging lot, the controlled-substance ledger entry and the qualified person responsible for release.
Around those release tests sits a deeper quality architecture: validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, calibrated sterilisation and depyrogenation equipment, validated terminal sterilisation cycles with load mapping for the ampoule format, and an electronic batch record system tied into our deviation, change-control and CAPA workflows. Stability is tracked under both long-term (30 °C / 65 % RH) and accelerated (40 °C / 75 % RH) ICH Q1A conditions — Zone IVb included — and the product is challenged against ICH Q1B photostability requirements.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Ephedrine HCL Injection manufacturer for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables across anaesthesia, pain-management, anti-infective, obstetric, neonatal and supportive-care categories. For Ephedrine HCL Injection specifically, we supply 30 mg/mL and 50 mg/mL strengths in 1 mL clear-glass ampoules under WHO-GMP conditions, with country-specific strengths, container formats and pack configurations available under contract manufacturing agreements. Every batch is released to WHO-GMP standards, with the underlying CTD or ACTD dossier — including the controlled-substance chain-of-custody package — ready to hand for registration.
Our CDMO services scale cleanly from single-hospital supply to full national tender procurement. We prepare complete eCTD and ACTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, controlled-substance import/export documentation, translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets, and coordinate shipping and logistics. When a buyer needs Ephedrine HCL Injection at tender scale our regulatory, manufacturing and logistics teams move as one: dossier, artwork, production slot and shipment plan delivered as a single coordinated package, with a single accountable point of contact.
Buyers stay with Farbe Firma because of audit-readiness and communication. Customer auditors are welcomed onto the plant floor and into the controlled-substance store; our quality unit answers technical queries with primary data, not slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, enantiomeric specification, controlled-substance reconciliation, pH control, sterilisation, container-closure and stability choices in real detail. For a drug given to mothers under spinal anaesthesia and to patients in active intraoperative hypotension, that openness is exactly what global buyers tell us they value most.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified Ephedrine HCL Injection manufacturer?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures Ephedrine HCL Injection at a Gujarat, India facility with ISO Class 5 aseptic processing, qualified clear-glass ampoule filling lines, qualified water-for-injection systems, validated terminal sterilisation cycles, segregated controlled-substance handling and continuous environmental monitoring.
Which strengths and pack sizes of Ephedrine HCL Injection do you supply?
Our standard presentations are 30 mg/mL and 50 mg/mL ephedrine hydrochloride solution in 1 mL clear-glass ampoules. Custom fill volumes, vial presentations and country-specific pack configurations are available under contract manufacturing agreements.
Can Farbe Firma support country-specific registrations and controlled-substance documentation for Ephedrine HCL Injection?
Yes. We provide full CTD and ACTD dossier modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, controlled-substance precursor import/export documentation, and translated package inserts and artwork for Spanish, French, Portuguese, Russian and Arabic markets.
How does Farbe Firma assure the potency and chain-of-custody of Ephedrine HCL Injection?
We control pH within a validated near-neutral specification, run HPLC assay with chiral verification of the (1R,2S)-(−)-ephedrine isomer and related-substances testing on every batch, reconcile every gram of API and every filled ampoule against a controlled-substance ledger with daily sign-off, package in clear-glass ampoules with light-protective secondary cartons, and qualify each batch against ICH Q1A and ICH Q1B.
What is the minimum order quantity for Ephedrine HCL Injection contract manufacturing?
MOQs vary by strength, container format, label complexity, controlled-substance import licence and dossier requirements. For the 30 mg/mL and 50 mg/mL ampoule presentations we accommodate hospital-scale and full-tender-scale orders. Contact director@farbefirma.org for a specific quotation.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments